NEURO-ONCOLOGY

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Improved neuropsychological outcomes following proton therapy relative to x-ray therapy for pediatric brain tumor patients.

An independently validated survival nomogram for lower grade glioma.

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma

Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013

EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma.

Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications.

Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life.

Introduction of novel agents in the treatment of primary CNS lymphoma.

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Driver mutations in USP8 wild-type Cushing’s disease

Sex-specific gene and pathway modeling of inherited glioma risk

Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.

Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA

Sex difference of mutation clonality in diffuse glioma evolution

Targeting Hypoxia Downstream Signaling Protein, CAIX, for CAR-T Cell Therapy against Glioblastoma.

Molecular Profiling of Long-Term IDH-wildtype Glioblastoma Survivors.

ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1

Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.

The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.

Deep-learning-based Detection and Segmentation-assisted Management on Brain Metastases.

Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns.

Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines*

Molecular correlates of cerebellar mutism syndrome in medulloblastoma.

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET - Clinical relevance in glioma patients.

Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

SECOND INTERIM AND FIRST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION

Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma

Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.

Xenograft-based platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Discovery of a new pyrimidine synthesis inhibitor eradicating glioblastoma-initiating cells.

Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.

Health status, Health-Related Quality of Life and Socio-economic Outcome in Childhood Brain Tumor Survivors: a German Cohort Study.

Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma

Gene therapy with apoptosis-associated speck-like protein (ASC), a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.

Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

A low percentage of metastases in deep brain and temporal lobe structures.

Differential Trajectories of Neurocognitive Functioning in Females versus Males Following Treatment for Pediatric Brain Tumors.

Hippocampal sparing radiotherapy in adults with primary brain tumours: a comparative planning and dosimetric study using IMPT, IMRT and 3DCRT.

Using surgical and oncology workload to plan brain tumour trial recruitment in England

To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.

EXTH-28. TARGETED POLYGIONS ENGINEERED WITH SURFACE miRNAs FOR COMBINED MULTIMODALITY IMAGING AND ENHANCEMENT OF TEMOZOLOMIDE TREATMENT: A NOVEL INTRANASALLY-DELIVERED THERANOSTIC STRATEGY AGAINST GLIOBLASTOMA

Determination of meningioma brain tissue grades using Raman hyperspectral imaging

The Glioma Elephant in The Room